AIA
DGX icon

Aventus Investment Advisors’s Quest Diagnostics DGX Stock Holding History

Aventus Investment Advisors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36K Hold
170
– – 0.03% 71
2026
Q1 		$33.3K Hold
170
– – 0.03% 71
2025
Q4 		$29.5K Hold
170
– – 0.02% 73
2025
Q3 		$32.4K Hold
170
– – 0.03% 68
2025
Q2 		$30.5K Buy
+170
New +$29.5K 0.03% 69

Other funds holding DGX

AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return
CPC
Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return
AIM
Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
SIC
Schwartz Investment Counsel Plymouth, Michigan $3.01B AUM 27.22% 1-Year Est. Return
BCAM
Boston Common Asset Management Boston, Massachusetts $1.69B AUM 28.29% 1-Year Est. Return

Aventus Investment Advisors's DGX Position: Q2 2026 in Review

Aventus Investment Advisors held its Quest Diagnostics (DGX) position steady in Q2 2026 at 170 shares worth $36K. The position accounts for 0.03% of the portfolio, ranked #71.

Aventus Investment Advisors first reported a position in DGX in Q2 2025 and has held it in 5 quarters since. 317 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Aventus Investment Advisors held 170 shares of Quest Diagnostics worth $36K as of Q2 2026.
  • Aventus Investment Advisors left its Quest Diagnostics share count unchanged in Q2 2026.
  • Quest Diagnostics made up 0.03% of Aventus Investment Advisors's portfolio in Q2 2026, its #71 holding.
  • Aventus Investment Advisors first reported a position in Quest Diagnostics in Q2 2025 and has held it in 5 quarters since.
  • 317 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Aventus Investment Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.